145 related articles for article (PubMed ID: 31368150)
1. Recurrence rate and associated factors of borderline ovarian tumors in the south of Vietnam.
Vo TM; Duong KA; Tran LT; Bui TC
J Obstet Gynaecol Res; 2019 Oct; 45(10):2055-2061. PubMed ID: 31368150
[TBL] [Abstract][Full Text] [Related]
2. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Epidemiology and Risk Factors of Relapse, Follow-up and Interest of a Completion Surgery].
Margueritte F; Sallee C; Lacorre A; Gauroy E; Larouzee E; Chereau E; De La Motte Rouge T; Koskas M; Gauthier T
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):248-259. PubMed ID: 32004784
[TBL] [Abstract][Full Text] [Related]
3. Borderline Ovarian Tumors: Fifteen Years' Experience at a Scottish Tertiary Cancer Center.
May J; Skorupskaite K; Congiu M; Ghaoui N; Walker GA; Fegan S; Martin CW; O'Donnell RL
Int J Gynecol Cancer; 2018 Nov; 28(9):1683-1691. PubMed ID: 30365457
[TBL] [Abstract][Full Text] [Related]
4. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Epidemiological Aspects and Risk Factors].
Ouldamer L; Body G; Daraï E; Bendifallah S
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):239-247. PubMed ID: 32004787
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors predicting recurrence in borderline ovarian tumors.
Wu TI; Lee CL; Wu MY; Hsueh S; Huang KG; Yeh CJ; Lai CH
Gynecol Oncol; 2009 Aug; 114(2):237-41. PubMed ID: 19481786
[TBL] [Abstract][Full Text] [Related]
6. What is the impact of stromal microinvasion on oncologic outcomes in borderline ovarian tumors? A multicenter case-control study.
Boyraz G; Salman MC; Gultekin M; Ozkan NT; Uckan HH; Gungorduk K; Gulseren V; Ayik H; Toptas T; Kuru O; Sozen H; Erturk A; Ozgul N; Meydanlı MM; Sanci M; Turan T; Gungor T; Simsek T; Topuz S; Yuce K
Arch Gynecol Obstet; 2017 Nov; 296(5):979-987. PubMed ID: 28866783
[TBL] [Abstract][Full Text] [Related]
7. Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk.
Vasconcelos I; de Sousa Mendes M
Eur J Cancer; 2015 Mar; 51(5):620-31. PubMed ID: 25661104
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for recurrence of borderline ovarian tumors in France: A multicenter retrospective study by the FRANCOGYN group.
Sangnier E; Ouldamer L; Bendifallah S; Huchon C; Collinet P; Bricou A; Mimoun C; Lecointre L; Graesslin O; Raimond E
J Gynecol Obstet Hum Reprod; 2021 Apr; 50(4):101961. PubMed ID: 33127559
[TBL] [Abstract][Full Text] [Related]
9. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
10. Is cystectomy an option as conservative surgery for young patients with borderline ovarian tumor? A multi-institutional retrospective study.
Ikeda Y; Yoshihara M; Yoshikawa N; Tamauchi S; Yokoi A; Nishino K; Niimi K; Kajiyama H
Int J Gynaecol Obstet; 2022 May; 157(2):437-443. PubMed ID: 34324200
[TBL] [Abstract][Full Text] [Related]
11. The Factors Predicting Recurrence in Patients With Serous Borderline Ovarian Tumor.
Ureyen I; Karalok A; Tasci T; Turkmen O; Boran N; Tulunay G; Turan T
Int J Gynecol Cancer; 2016 Jan; 26(1):66-72. PubMed ID: 26512785
[TBL] [Abstract][Full Text] [Related]
12. Comparison of stage III mucinous and serous ovarian cancer: a case-control study.
Firat Cuylan Z; Karabuk E; Oz M; Turan AT; Meydanli MM; Taskin S; Sari ME; Sahin H; Ulukent SC; Akbayir O; Gungorduk K; Gungor T; Kose MF; Ayhan A
J Ovarian Res; 2018 Oct; 11(1):91. PubMed ID: 30376858
[TBL] [Abstract][Full Text] [Related]
13. Characterization and Management of Borderline Ovarian Tumors - Results of a Retrospective, Single-center Study of Patients Treated at the Department of Gynecology and Obstetrics of the University Medicine Greifswald.
Koensgen D; Weiss M; Assmann K; Brucker SY; Wallwiener D; Stope MB; Mustea A
Anticancer Res; 2018 Mar; 38(3):1539-1545. PubMed ID: 29491083
[TBL] [Abstract][Full Text] [Related]
14. Identification of factors that impact recurrence in patients with borderline ovarian tumors.
Chen X; Fang C; Zhu T; Zhang P; Yu A; Wang S
J Ovarian Res; 2017 Apr; 10(1):23. PubMed ID: 28376898
[TBL] [Abstract][Full Text] [Related]
15. Borderline tumours of the ovary: A cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group.
du Bois A; Ewald-Riegler N; de Gregorio N; Reuss A; Mahner S; Fotopoulou C; Kommoss F; Schmalfeldt B; Hilpert F; Fehm T; Burges A; Meier W; Hillemanns P; Hanker L; Hasenburg A; Strauss HG; Hellriegel M; Wimberger P; Keyver-Paik MD; Baumann K; Canzler U; Wollschlaeger K; Forner D; Pfisterer J; Schröder W; Münstedt K; Richter B; Kommoss S; Hauptmann S;
Eur J Cancer; 2013 May; 49(8):1905-14. PubMed ID: 23490647
[TBL] [Abstract][Full Text] [Related]
16. The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors.
Fang C; Zhao L; Chen X; Yu A; Xia L; Zhang P
BMC Cancer; 2018 Nov; 18(1):1147. PubMed ID: 30463533
[TBL] [Abstract][Full Text] [Related]
17. Borderline ovarian tumor in women aged ≥ 65 years: impact on recurrence and survival.
Song T; Lee YY; Choi CH; Kim TJ; Lee JW; Bae DS; Kim BG
Eur J Obstet Gynecol Reprod Biol; 2015 Jan; 184():38-42. PubMed ID: 25463633
[TBL] [Abstract][Full Text] [Related]
18. Surgical staging and prognosis in serous borderline ovarian tumours (BOT): a subanalysis of the AGO ROBOT study.
Trillsch F; Mahner S; Vettorazzi E; Woelber L; Reuss A; Baumann K; Keyver-Paik MD; Canzler U; Wollschlaeger K; Forner D; Pfisterer J; Schroeder W; Muenstedt K; Richter B; Fotopoulou C; Schmalfeldt B; Burges A; Ewald-Riegler N; de Gregorio N; Hilpert F; Fehm T; Meier W; Hillemanns P; Hanker L; Hasenburg A; Strauss HG; Hellriegel M; Wimberger P; Kommoss S; Kommoss F; Hauptmann S; du Bois A
Br J Cancer; 2015 Feb; 112(4):660-6. PubMed ID: 25562434
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological analysis of borderline ovarian tumours and risk factors related to recurrence: experience of single institution.
Sozen H; Vatansever D; Topuz S; Iyibozkurt C; Kandemir H; Yalçin I; Onder S; Yavuz E; Salihoglu Y
J Obstet Gynaecol; 2019 Feb; 39(2):253-258. PubMed ID: 30372646
[TBL] [Abstract][Full Text] [Related]
20. Borderline Ovarian Tumor in the Pediatric and Adolescent Population: A Case Series and Literature Review.
Childress KJ; Patil NM; Muscal JA; Dietrich JE; Venkatramani R
J Pediatr Adolesc Gynecol; 2018 Feb; 31(1):48-54. PubMed ID: 28899828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
